Your Health, We Care
Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
from FDA，2024.08
Fezolinetant is indicated for the treatment of vasomotor symptoms due to menopau···【more】
Release date：2026-01-05Recommended：18
LuciusVersionofFezolinetant:DosageandAdministration,Indications,PrecautionsIndic···【more】
Release date：2025-12-10Recommended：54
Lucius Version of Fezolinetant: Dosage and Administration, Indications, Precauti···【more】
Release date：2025-12-09Recommended：56
